SGMO Financial Facts

Research and development: 13.43M
Net loss: -6.98M
See Full Income Statement

Property and equipment, net: 1.62M
Accumulated deficit: -316.69M
See Full Balance Sheet

Sangamo Biosciences Inc. (SGMO) Earnings

  |   Expand Research on SGMO
Next EPS Date 10/22/14 EPS Growth Rate +63.6%
Average EPS % Beat Rate +14.8% Revenue Growth Rate +45.1%
Average % Move 1-Wk after EPS -1.7% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/22/14 Q314 N/A-$0.04 N/A N/A$8.27M N/A N/A N/A
7/23/14 Q214 -$0.10-$0.14 +$0.04$10.4M$7.84M N/A Details
5/6/14 Q114 -$0.12-$0.13 +$0.01$8.1M$6.59M N/A Details
2/11/14 Q413 -$0.13N/A N/A $6.9M$8.9M N/A Details
10/23/13 Q313 -$0.11-$0.11 $0.00$5.7M$5.52M = Details
7/24/13 Q213 -$0.10-$0.13 +$0.03$6.93M$4.77M = Details
5/8/13 Q113 -$0.13-$0.16 +$0.03$4.62M$3.79M = Details
2/6/13 Q412 -$0.07-$0.12 +$0.05$8.9M$5.95M = Details